AAAAAA

   
Results: 1-12 |
Results: 12

Authors: BOTTASSO B COPPOLA R BAJETTA MT DIROCCO N ALBERIO G FATTI L INVITTI C CAVAGNINI F MANNUCCI PM
Citation: B. Bottasso et al., HEMOSTATIC AND FIBRINOLYTIC MARKERS IN PATIENTS WITH CUSHINGS-DISEASE, Thrombosis research, 91(3), 1998, pp. 4-4

Authors: COPPOLA R ALBERIO G DIROCCO N BRESSI C BIGANZOLI M PASSONI E RIGONI C MANNUCCI PM
Citation: R. Coppola et al., EFFECTS OF ETHYNILOESTRADIOL-CYPROTERONE ACETATE ON TISSUE FACTOR PATHWAY AND CONTACT PHASE COMPONENTS, Thrombosis research, 91(3), 1998, pp. 17-17

Authors: MARI D DIROCCO N COPPOLA R BOTTASSO B BAJETTA MT ALBERIO G BOIOCCHI D MUTTI M VICARI F CUGNO M GRONDA E
Citation: D. Mari et al., ACTIVATION OF PROTEASIC SYSTEMS IN PATIENTS WITH LEFT-VENTRICLE ASSIST DEVICES (LVAD), Thrombosis research, 91(3), 1998, pp. 18-18

Authors: COPPOLA R LATTUADA A ALBERIO G DIROCCO N MENEGATTI M BIGANZOLI M MARI D
Citation: R. Coppola et al., VON-WILLEBRAND-FACTOR AND LONGEVITY, Thrombosis research, 91(3), 1998, pp. 19-19

Authors: PEYVANDI F MANNUCCI PM ASTI D ABDOULLAHI M DIROCCO N SHARIFIAN R
Citation: F. Peyvandi et al., CLINICAL MANIFESTATIONS IN 28 ITALIAN AND IRANIAN PATIENTS WITH SEVERE FACTOR-VII DEFICIENCY, Haemophilia, 3(4), 1997, pp. 242-246

Authors: ARIENS R ARDISSINO D MERLINI PA COPPOLA R COLOMBI E BOTTASSO B BRAMUCCI E ANGOLI L DIROCCO N ALBERIO G MANNUCCI PM
Citation: R. Ariens et al., THROMBOGENIC POTENTIAL OF HUMAN CORONARY ATHEROSCLEROTIC PLAQUES, Thrombosis and haemostasis, 1997, pp. 748-748

Authors: FEDERICI AB MANNUCCI PM STABILE F CANCIANI MT DIROCCO N MIYATA S WARE J RUGGERI ZM
Citation: Ab. Federici et al., A TYPE 2B VAN-WILLEBRAND-DISEASE MUTATION (ILE(546)-]VAL) ASSOCIATED WITH AN UNUSUAL PHENOTYPE, Thrombosis and haemostasis, 78(3), 1997, pp. 1132-1137

Authors: BIERTI L CEMUSCHI C ABBIATI C BECCARI G DIBATTISTA R MARCHI R FEDERICI A BOTTASSO B DIROCCO N DEFRANCHIS R MANNUCCI PM
Citation: L. Bierti et al., CORRELATION BETWEEN GASTRIC INFECTION WITH HELICOBACTER-PYLORI AND PLASMA-LEVELS OF FIBRINOGEN, PLASMINOGEN-ACTIVATOR INHIBITOR (PAI) AND VON-WILLEBRAND-FACTOR (VWF) ANTIGEN, Gastroenterology, 110(4), 1996, pp. 65-65

Authors: FEDERICI AB FALANGA A LATTUADA A DIROCCO N BARBUI T MANNUCCI PM
Citation: Ab. Federici et al., PROTEOLYSIS OF VON-WILLEBRAND-FACTOR IS DECREASED IN ACUTE PROMYELOCYTIC LEUKEMIA BY TREATMENT WITH ALL-TRANS-RETINOIC ACID, British Journal of Haematology, 92(3), 1996, pp. 733-739

Authors: BERGAMASCHINI L CIAVARELLA N FEDERICI A DIROCCO N SCHIAVONI M STEFANILE C MANNUCCI PM
Citation: L. Bergamaschini et al., POSTTRANSFUSIONAL NON-IGE MEDIATED ANAPHYLAXIS IN 2 PATIENTS WITH VON-WILLEBRAND DISEASE TYPE-III WITH INHIBITOR - THE ROLE OF IGG SUBCLASSES, Thrombosis and haemostasis, 73(6), 1995, pp. 1167-1167

Authors: FEDERICI AB FALANGA A LATTUADA A DIROCCO N BARBUI T MANNUCCI PM
Citation: Ab. Federici et al., INCREASED PROTEOLYSIS OF VON-WILLEBRAND-FACTOR IN ACUTE PROMYELOCYTICLEUKEMIA - PROGRESSIVE CORRECTION WITH TRANSIENT APPEARANCE OF SUPRANORMAL MULTIMERS FOLLOWING TREATMENT WITH ALL-TRANS-RETINOIC ACID, Thrombosis and haemostasis, 73(6), 1995, pp. 1433-1433

Authors: FEDERICI AB FALANGA A LATTUADA A DIROCCO N BARBUI T MANNUCCI PM
Citation: Ab. Federici et al., PROTEOLYSIS OF VON-WILLEBRAND-FACTOR IS DECREASED IN ACUTE PROMYELOCYTIC LEUKEMIA BY TREATMENT WITH ALL-TRANS-RETINOIC ACID, Blood, 86(10), 1995, pp. 3022-3022
Risultati: 1-12 |